This inventor holds 2 USPTO granted patents. Top assignee: Sunstar Kabushiki Kaisha. Active years: 1986.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1986
Title: Mitsunobu Sato: Innovator in Pharmaceutical Composition
Introduction
Mitsunobu Sato is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of skin and mucosal disorders. With a total of 2 patents, Sato's work focuses on innovative compositions that address various medical conditions.
Latest Patents
Sato's latest patents include a composition and method for treating keratosic disorders of the skin and mucosa. This pharmaceutical composition is designed for conditions such as lichen planus and leukoplakia. It comprises an effective amount of human interferon, a trihydric or higher polyhydric sugar alcohol, an organic acid buffer, and optionally, an anionic surfactant and albumin, along with a conventional pharmaceutical carrier or diluent. Additionally, he has developed a composition and method for treating erythematodes and mycosis, particularly lupus erythematodes discoides and candidiasis. This composition also utilizes human interferon and similar components for effective treatment.
Career Highlights
Mitsunobu Sato is associated with Sunstar Kabushiki Kaisha, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing effective treatments for challenging medical conditions.
Collaborations
Sato has collaborated with notable colleagues such as Yasuhiro Katsuragi and Yasuo Sakano, contributing to the advancement of pharmaceutical research and development.
Conclusion
Mitsunobu Sato's contributions to pharmaceutical compositions demonstrate his commitment to improving medical treatments. His innovative patents reflect a deep understanding of complex medical conditions and a dedication to enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
